Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats.
The numbers of monocytes and macrophages in the walls of cerebral blood vessels were counted on perfusion-fixed frozen brain sections (16 microns) of spontaneously hypertensive rats (SHR), stroke-prone SHR (SHR-SP), normotensive Wistar-Kyoto (WKY) rats, and young (16-week-old) and old (2-year-old) normotensive Sprague-Dawley rats (SD-16w and SD-2y, respectively) using monoclonal antibodies against rat macrophages (ED2). The staining was visualized with fluorescein-labeled second antibodies. The ED2-specific staining in brain sections was restricted to macrophages in a perivascular location. The number of perivascular cells per square millimeter of high-power field was significantly greater in SHR-SP (8.6 +/- 2.1; n = 4) and SHR (6.7 +/- 0.9; n = 6) than in normotensive WKY (4.0 +/- 0.5; n = 6; p < 0.01). The number of perivascular macrophages was also greater in SD-2y (7.5 +/- 2.7; n = 9) than in SD-16w (2.9 +/- 1.8; n = 8; p < 0.01). No ED2 staining was found in the resident microglia or in the endothelial cells, which were identified by double staining with rhodamine-labeled anti-factor VIII-related antigen antibodies. The results suggest that the stroke risk factors hypertension and advanced age are associated with increased subendothelial accumulation of monocytes and macrophages. This accumulation could increase the tendency for the endothelium to convert from an anticoagulant to a procoagulant surface in response to mediators released from these subendothelial cells.
Liu
Y
Y
Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814.
Jacobowitz
D M
DM
Barone
F
F
McCarron
R
R
Spatz
M
M
Feuerstein
G
G
Hallenbeck
J M
JM
Sirén
A L
AL
D000375:Aging / Q000502:physiology*; D000818:Animals; D000911:Antibodies, Monoclonal; D001808:Blood Vessels / Q000473:pathology; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000473:pathology; D016650:Fluorescein-5-isothiocyanate; D005455:Fluorescent Antibody Technique; D006973:Hypertension / Q000473:pathology*; D008264:Macrophages / Q000473:pathology*; D008297:Male; D009000:Monocytes / Q000473:pathology*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D017207:Rats, Sprague-Dawley; D014841:von Willebrand Factor / Q000378:metabolism
D000911:Antibodies, Monoclonal; D014841:von Willebrand Factor; D016650:Fluorescein-5-isothiocyanate